Literature DB >> 8800343

Memory deficits and early cognitive deterioration in MS.

P Kujala1, R Portin, J Ruutiainen.   

Abstract

INTRODUCTION: In the present study, the pattern of memory and learning deficits in two cognitively different, but clinically and demographically similar, multiple sclerosis (MS) groups was compared. MATERIAL &
METHODS: 23 patients represented the cognitively preserved MS group and 22 patients the MS group with early cognitive decline. A control group of 35 healthy controls was also included. The cognitive status of the subjects was defined using the Mild Deterioration Battery (MDB). Furthermore, all subjects were given a set of memory and learning tests and were instructed to evaluate the frequency of their memory and learning difficulties. The Mini-Mental State Examination (MMSE) was also administered to all subjects.
RESULTS: The cognitively deteriorated patients, even those with normal MMSE performance, showed widespread memory and learning deficits, but adequate self-evaluation of their everyday memory and learning difficulties. The preserved group, in turn, performed similarly to the controls.
CONCLUSION: Widespread memory and learning deficits are associated with relatively mild cognitive decline in MS. These deficits were observable in the intermediate-length screening battery, the MDB, but not in the MMSE. The present study suggests that the accuracy of patients' own evaluations of their memory and other cognitive problems is superior to the results of very brief screening batteries, like the MMSE. Therefore, brief screening in neuropsychological assessment of MS patients is not recommendable.

Entities:  

Mesh:

Year:  1996        PMID: 8800343     DOI: 10.1111/j.1600-0404.1996.tb00005.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  8 in total

1.  Capacity to make medical treatment decisions in multiple sclerosis: a potentially remediable deficit.

Authors:  Michael R Basso; Philip J Candilis; Jay Johnson; Courtney Ghormley; Dennis R Combs; Taeh Ward
Journal:  J Clin Exp Neuropsychol       Date:  2010-12       Impact factor: 2.475

Review 2.  Cognitive impairment in early stages of multiple sclerosis.

Authors:  Maria Pia Amato; E Portaccio; B Goretti; V Zipoli; B Hakiki; M Giannini; L Pastò; L Razzolini
Journal:  Neurol Sci       Date:  2010-11       Impact factor: 3.307

3.  The role of disability and depression in cognitive functioning within 2 years after multiple sclerosis diagnosis.

Authors:  T A M Siepman; A C J W Janssens; I de Koning; C H Polman; J B Boringa; R Q Hintzen
Journal:  J Neurol       Date:  2008-05-20       Impact factor: 4.849

4.  Longitudinal study of cognitive dysfunction in multiple sclerosis: neuropsychological, neuroradiological, and neurophysiological findings.

Authors:  M R Piras; I Magnano; E D G Canu; K S Paulus; W M Satta; A Soddu; M Conti; A Achene; G Solinas; I Aiello
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-07       Impact factor: 10.154

5.  Validation of an obstructive sleep apnea symptom inventory in persons with multiple sclerosis.

Authors:  Mini Singh; Ronald Gavidia; Galit Levi Dunietz; Elizabeth Washnock-Schmid; Andrew R Romeo; Shelley Hershner; Ronald D Chervin; Tiffany J Braley
Journal:  Mult Scler       Date:  2021-05-28       Impact factor: 6.312

6.  Music mnemonics aid Verbal Memory and Induce Learning - Related Brain Plasticity in Multiple Sclerosis.

Authors:  Michael H Thaut; David A Peterson; Gerald C McIntosh; Volker Hoemberg
Journal:  Front Hum Neurosci       Date:  2014-06-13       Impact factor: 3.169

7.  Overview: A Framework for the Discussion of Sleep in Multiple Sclerosis.

Authors:  Tiffany J Braley
Journal:  Curr Sleep Med Rep       Date:  2017-10-28

8.  Adaptive vs. non-adaptive cognitive training by means of a personalized App: a randomized trial in people with multiple sclerosis.

Authors:  Ludovico Pedullà; Giampaolo Brichetto; Andrea Tacchino; Claudio Vassallo; Paola Zaratin; Mario Alberto Battaglia; Laura Bonzano; Marco Bove
Journal:  J Neuroeng Rehabil       Date:  2016-10-04       Impact factor: 4.262

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.